Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

AIFF

Firefly Neuroscience (AIFF)

Firefly Neuroscience Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AIFF
일자시간출처헤드라인심볼기업
2025/02/1506:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AIFFFirefly Neuroscience Inc
2025/02/1414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AIFFFirefly Neuroscience Inc
2025/02/1121:45GlobeNewswire Inc.Firefly Neuroscience Accepted into NVIDIA Connect ProgramNASDAQ:AIFFFirefly Neuroscience Inc
2025/02/0721:30GlobeNewswire Inc.Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum ElectronicsNASDAQ:AIFFFirefly Neuroscience Inc
2025/02/0614:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AIFFFirefly Neuroscience Inc
2025/01/2423:00GlobeNewswire Inc.Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric CareNASDAQ:AIFFFirefly Neuroscience Inc
2025/01/2123:10Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AIFFFirefly Neuroscience Inc
2025/01/1505:50AllPennyStocks.comThis Micro Cap Soared On Key AnnouncementNASDAQ:AIFFFirefly Neuroscience Inc
2025/01/1421:45GlobeNewswire Inc.Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ PlatformNASDAQ:AIFFFirefly Neuroscience Inc
2025/01/0906:45Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AIFFFirefly Neuroscience Inc
2025/01/0906:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AIFFFirefly Neuroscience Inc
2025/01/0706:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AIFFFirefly Neuroscience Inc
2024/12/3123:00GlobeNewswire Inc.Firefly Neuroscience Closes on Financing of up to $12.4 MillionNASDAQ:AIFFFirefly Neuroscience Inc
2024/12/2806:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AIFFFirefly Neuroscience Inc
2024/12/2406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AIFFFirefly Neuroscience Inc
2024/12/0707:16Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AIFFFirefly Neuroscience Inc
2024/12/0707:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AIFFFirefly Neuroscience Inc
2024/12/0423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AIFFFirefly Neuroscience Inc
2024/12/0423:00GlobeNewswire Inc.Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive ChairmanNASDAQ:AIFFFirefly Neuroscience Inc
2024/12/0420:16Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AIFFFirefly Neuroscience Inc
2024/12/0407:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AIFFFirefly Neuroscience Inc
2024/11/1507:30GlobeNewswire Inc.Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder UpdateNASDAQ:AIFFFirefly Neuroscience Inc
2024/11/1507:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AIFFFirefly Neuroscience Inc
2024/11/0623:00GlobeNewswire Inc.Firefly Neuroscience to Participate in the 8th Annual Florida Capital EventNASDAQ:AIFFFirefly Neuroscience Inc
2024/11/0205:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AIFFFirefly Neuroscience Inc
2024/10/2605:10GlobeNewswire Inc.Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AIFFFirefly Neuroscience Inc
2024/10/2505:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AIFFFirefly Neuroscience Inc
2024/10/2121:30GlobeNewswire Inc.Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG DataNASDAQ:AIFFFirefly Neuroscience Inc
2024/10/1622:20GlobeNewswire Inc.Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ TechnologyNASDAQ:AIFFFirefly Neuroscience Inc
2024/10/1522:00GlobeNewswire Inc.Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive DisorderNASDAQ:AIFFFirefly Neuroscience Inc
 검색 관련기사 보기:NASDAQ:AIFF